n.a. (ZMH)

pos +0.00
Today's Range: 0.00 - 0.00 | ZMH Avg Daily Volume: 0
Last Update: 12/31/69 - 7:00 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $0.00
52 Week Range: $0.00 - $0.00
Oustanding Shares: 170,402,000
Market Cap: 0
6-Month Chart
TheStreet Ratings Grade for ZMH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
ZMH Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for ZMH:
Revenue 0.00B
Average Earnings Estimates

Earnings Estimates data is not available for ZMH.

Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Bruce Kamich

 | Jun 6, 2016 | 10:04 AM EDT

Point and figure price projections measure as high as $188 for ZBH.

bearishZimmer downgraded at Brean

Jun 25, 2015 | 6:43 AM EDT

ZMH was downgraded from Buy to Hold, Brean Capital said. Company lacks near-term catalysts. 


David Katz

 | May 6, 2015 | 7:00 AM EDT

Investors should step up even before Biomet acquisition OK'd.

bearishZimmer estimates, target cut at BMO

May 4, 2015 | 8:29 AM EDT

ZMH estimates were reduced through 2016, BMO Capital said. Management lowered guidance. Outperform rating and new $132 price target. 

bearishZimmer estimates, target reduced at Leerink

May 1, 2015 | 8:00 AM EDT

Shares of ZMH now seen reaching $130, according to Leerink Partners. Estimates also cut, given the stronger dollar. Outperform rating. 

bullishZimmer upgraded at Jefferies

Feb 3, 2015 | 7:24 AM EST

ZMH was upgraded from Hold to Buy, Jefferies said. Valuation call, based on a $131 price target. 

bearishZimmer downgraded at Needham

Jan 30, 2015 | 6:28 AM EST

ZMH was downgraded from Strong Buy to Buy, Needham said. Valuation call, based on a $131 price target. 

bullishZimmer upgraded at JP Morgan

Jan 5, 2015 | 7:16 AM EST

ZMH was upgraded from Neutral to Overweight, JP Morgan said. $136 price target. Management can unlock value, by integrating the Biomet purchase. 

bullishZimmer upgraded at Morgan Stanley

Jan 5, 2015 | 6:39 AM EST

ZMH was upgraded from Equal-weight to Overweight, Morgan Stanley said. $134 price target. Valuation call, as Biomet should help drive growth. 


Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

As far as TSLA is concerned, I still have a higher target above the market at the 409 area...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it v...
BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after openin...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.